Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02495896
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:00.191180+00:00
Published At
2025-11-10T00:00:00+00:00
Record Updated At
2025-11-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Squamous Cell Carcinoma", "Metastatic Pancreatic Adenocarcinoma", "Non-Resectable Cholangiocarcinoma", "Pancreatic Adenocarcinoma", "Recurrent Gallbladder Carcinoma", "Recurrent Non-Small Cell Lung Carcinoma", "Stage III Pancreatic Cancer", "Stage IIIA Gallbladder Cancer", "Stage IIIA Non-Small Cell Lung Cancer", "Stage IIIB Gallbladder Cancer", "Stage IIIB Non-Small Cell Lung Cancer", "Stage IV Gallbladder Cancer", "Stage IV Non-Small Cell Lung Cancer", "Stage IV Pancreatic Cancer", "Unresectable Gallbladder Carcinoma", "Unresectable Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-10"
protocolSection.identificationModule.nctId
"NCT02495896"
protocolSection.identificationModule.officialTitle
"A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid Tumors"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Non-Resectable Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Non-Small Cell Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Unresectable Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.